Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Foresite Capital Management is a multi-stage healthcare and life sciences investment firm that aims to address areas of great unmet medical need. They leverage deep scientific, medical, and data science expertise to invest in and support innovative companies across therapeutics, diagnostics, genomics, and healthcare technology. Foresite Capital invests in both private and public companies, seeking to accelerate the development of groundbreaking solutions that can improve patient lives.
The San Francisco headquarters serves as the central nexus for the firm's investment decisions, portfolio management, due diligence processes, and overall strategic direction. It houses key leadership and operational teams.
Situated in a prominent office tower in the Financial District, offering modern facilities, advanced technological infrastructure, and collaborative workspaces conducive to innovation and strategic planning.
The work culture at Foresite Capital is characterized by intellectual rigor, a strong emphasis on scientific and data-driven analysis, collaboration, and a passion for advancing healthcare. Employees are typically experts in their respective fields.
The San Francisco location provides Foresite Capital with direct access to a dense ecosystem of biotech startups, research institutions, talent, and co-investors, which is critical for deal sourcing and staying at the forefront of industry trends.
Foresite Capital Management operates with a global perspective, primarily through its key offices in North America (San Francisco, New York) and Europe (London). These locations enable the firm to source investments, conduct due diligence, and support portfolio companies across major healthcare innovation hubs worldwide. Their investment strategy often involves companies with global market potential, requiring international support for clinical trials, regulatory approvals, and commercialization.
One Maritime Plaza, Suite 1150
San Francisco
California
USA
Address: 780 Third Avenue, 25th Floor, New York, NY 10017
To leverage proximity to Wall Street, East Coast pharmaceutical companies, and research institutions for investment opportunities and strategic partnerships.
Address: 16 Berkeley Street, London W1J 8DZ, UK
To tap into the European innovation landscape, build relationships with international partners, and support the global expansion of portfolio companies.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Foresite Capital' leadership includes:
Foresite Capital has been backed by several prominent investors over the years, including:
In the last 12 months, Foresite Capital has seen some key personnel changes, including internal promotions to Managing Director and strategic hires to bolster investor relations and business development functions. Public information on exits is limited.
Discover the tools Foresite Capital uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Foresite Capital Management likely utilizes common corporate email formats. Based on industry patterns and available data, the most probable format is the first initial followed by the last name.
[first_initial][last]@foresitecapital.com
Format
jtananbaum@foresitecapital.com
Example
90%
Success rate
BioSpace • February 14, 2024
Alumis Inc., a precision immunology company incubated by Foresite Labs and backed by Foresite Capital, has raised $259 million in an oversubscribed Series C financing round. The proceeds will advance its portfolio of oral therapies targeting autoimmune diseases, including ESK-001, a highly selective TYK2 inhibitor....more
Business Wire • January 9, 2024
Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced the promotion of Hadi Tabbaa, Ph.D., CFA, to Managing Director. Dr. Tabbaa joined Foresite in 2019 and has been instrumental in sourcing and managing investments across therapeutics and life sciences....more
Foresite Capital Website (Press Release) • November 1, 2023
Foresite Capital announced that Molly Wogan has joined the firm as Partner, Investor Relations and Business Development. She brings extensive experience in capital formation and limited partner relationships within the alternative asset management industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Foresite Capital, are just a search away.